Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation
- 16 January 2023
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (2) , 1-14
Abstract
Defining drivers of tumour initiation can provide opportunities to control cancer progression. Here we report that lysophosphatidic acid receptor 4 (LPAR4) becomes transiently upregulated on pancreatic cancer cells exposed to environmental stress or chemotherapy where it promotes stress tolerance, drug resistance, self-renewal and tumour initiation. Pancreatic cancer cells gain LPAR4 expression in response to stress by downregulating a tumour suppressor, miR-139-5p. Even in the absence of exogenous lysophosphatidic acid, LPAR4-expressing tumour cells display an enrichment of extracellular matrix genes that are established drivers of cancer stemness. Mechanistically, upregulation of fibronectin via an LPAR4/AKT/CREB axis is indispensable for LPAR4-induced tumour initiation and stress tolerance. Moreover, ligation of this fibronectin-containing matrix via integrins α5β1 or αVβ3 can transfer stress tolerance to LPAR4-negative cells. Therefore, stress- or drug-induced LPAR4 enhances cell-autonomous production of a fibronectin-rich extracellular matrix, allowing cells to survive ‘isolation stress’ and compensate for the absence of stromal-derived factors by creating their own tumour-initiating niche.Keywords
Funding Information
- Foundation for the National Institutes of Health (R01CA045726, R35CA220512)
This publication has 53 references indexed in Scilit:
- Pancreas-Specific Cre Driver Lines and Considerations for Their Prudent UseCell Metabolism, 2013
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Fibronectin and stem cell differentiation – lessons from chondrogenesisJournal of Cell Science, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytesBiochemical and Biophysical Research Communications, 2009
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progressionNature Medicine, 2009
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assaysJournal of Immunological Methods, 2009
- CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer TherapyClinical Cancer Research, 2009
- LPA 1 receptors mediate stimulation, whereas LPA 2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascitesCarcinogenesis, 2009
- Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1Journal of Biological Chemistry, 2004